DOCSLIB.ORG

OVULATION 2010 ABS Ok Ok Okst

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
OVULATION 2010 ABS Ok Ok Okst Presidents of the Congress Professor Marco Filicori Chairman GynePro Medical Group, Bologna, Italy Professor Giuseppe De Placido Head Reproductive Medicine Unit Department of Obstetrics and Gynecology University of Naples “Federico II”, Naples, Italy International Scientific Committee Fleming R (UK) Hugues JN (FR) Macklon NS (UK) FACULTY Nardo L (UK) Pellicer A (ES) Ubaldi F (IT) Italian Scientific Committee Caserta D (IT) Chiantera A (IT) Cicinelli E (IT) Colacurci N (IT) Colao A (IT) Crosignani PG (IT) Dessole S (IT) Genazzani AR (IT) Locci M (IT) Moscarini M (IT) Nappi C (IT) Perino A (IT) Petraglia F (IT) Pivonello R (IT) Volpe A (IT) Zullo F (IT) Local Organizing Committee Clarizia R (IT) Mollo A (IT) Ranieri A (IT) Strina I (IT) E.C.M. • Continued Medical Education The congress participates in the Continued Medical Education National Program instituited by the Italian Ministry of Health. The credits assignment is being processed. www.ovulationinduction2010.org ENDORSEMENTS SOTTO L’ALTO PATRONATO DEL PRESIDENTE DELLA REPUBBLICA ITALIANA www.quirinale.it MINISTERO DELLA SALUTE www.salute.gov.it REGIONE CAMPANIA www.regione.campania.it COMUNE DI NAPOLI www.comune.napoli.it ALMA MATER STUDIORUM UNIVERSITÀ DI BOLOGNA FACOLTÀ DI MEDICINA E CHIRURGIA www.unibo.it UNIVERSITÀ DEGLI STUDI DI NAPOLI FEDERICO II FACOLTÀ DI MEDICINA E CHIRURGIA www.unina.it SECONDA UNIVERSITÀ DEGLI STUDI DI NAPOLI www.unina2.it MIDDLE EAST FERTILITY SOCIETY www.mefs.org AGUI ASSOCIAZIONE GINECOLOGI UNIVERSITARI ITALIANI www.aguionline.it AOGOI ASSOCIAZIONE OSTETRICI GINECOLOGI OSPEDALIERI ITALIANI www.aogoi.it SIGO SOCIETA' ITALIANA DI GINECOLOGIA E OSTETRICIA www.sigo.it ORDINE DEI MEDICI CHIRURGHI E ODONTOIATRI DI NAPOLI E PROVINCIA www.ordinemedicinapoli.it GENERAL INFORMATION Congress Venue Royal Continental Hotel Via Partenope 38/44 I 80121 Napoli, Italy www.royalcontinental.it Tel. +39 081 245 2068 Fax +39 081 764 4616 [email protected] WE THANK Scientific Secretariat Dr. Graciela E. Cognigni Dr. Lodovico Parmegiani Ferring International GynePro Medical Centers Center S.A. Via T. Cremona 8 Chemin de la Vergognausaz, 50 CH - 1162 Saint Prex - SWITZERLAND I-40137 Bologna, Italy Phone +41 58 301 00 00 Fax +41 58 301 00 10 Tel. +39 051 442094 www.ferring.com Fax +39 051 441135 [email protected] IBSA Institut Biochimique S.A. Via del Piano, 11 Dr. Carlo Alviggi 6915 Pambio Noranco - SWITZERLAND Reproductive Medicine Phone +41 58 360 1000 Department of Obstetrics Fax +41 58 360 1677 www.ibsa-international.com and Gynecology University of Napoli "Federico II" Merck Serono S.p.A. Via Sergio Pansini 5 Via Casilina, 125 I-80131 Napoli, Italy 00176 Roma (RM) - ITALY Phone +39 06 703841 Tel. +39 081 746 2699 Fax +39 06 70384643 Fax +39 081 746 3747 www.merckserono.it [email protected] Merck Serono S.A. 9, chemin des Mines, Case postale 54 CH-1211 Geneva 20 - SWITZERLAND Phone +41 22 414 3000 Organizing Secretariat Fax: +41 22 414 2179 www.merckserono.com Schering-Plough S.p.A. Via Fratelli Cervi snc 20090 Segrate (MI) - ITALY GynePro Educational Phone +39 02 210181 Fax +39 02 21018602 Via Lame, 44 www.schering-plough.it I-40122 Bologna, Italy Tel. +39 051 223260 Fax +39 051 222101 Takeda Italia Farmaceutici S.p.A. [email protected] Via E. Vittorini, 129 00144 Roma (RM) - ITALY Phone +39 06 50260 Fax +39 06 5011709 www.takeda.it www.gynepro.it PROGRAM AT A GLANCE Thursday Friday Saturday 30 September 2010 1 October 2010 2 October 2010 morning 8:30-10:45 8:30-11:00 Session 1I Session IV ANOVULATION AND FSH FORMULATIONS MILD STIMULATION AND REGIMENS 10:45-11:15 11:00-11:30 coffee break coffee break 11:15-12:45 11:30-13:00 IBSA MERCK SERONO SYMPOSIUM SYMPOSIUM 13:00-14:00 13:00-14:00 lunch lunch afternoon 13:15-13:45 Opening Ceremony 14:00-16:15 14:00-16:10 Session III Session V 13:45-14:30 GnRH LH ACTIVITY: Keynote Lecture ANALOGS FORMULATIONS AND REGIMENS 14:30-17:00 Session 1 14:00-16:00 14:00-15:45 BASIC ASPECTS FREE ORAL COMMUNICATIONS FREE ORAL COMMUNICATIONS Session I Session II 17:00-17:30 coffee break 16:15-17:00 16:10-16:40 coffee break coffee break 17:30-19:00 FERRING 17:00-18:30 16:40-18:45 SYMPOSIUM Session VI SCHERING-PLOUGH SPECIAL REGIMENS 19:00 SYMPOSIUM Welcome Reception 18:45 at Castel dell’Ovo Close of the Congress Thursday • 30 September OPENING CEREMONY AUDITORIUM 13:15 Welcome and Opening of the Congress Filicori M (IT) De Placido G (IT) 5 13:45 KEYNOTE LECTURE The ovarian lifecycle: from genesis to preservation (AB-00) Oktay K (US) AUDITORIUM SESSION I BASIC ASPECTS Sponsored by IBSA PHARMACEUTICALS Chairpersons: Fleming R (UK), Di Carlo C (IT) 14:30 Genetics of folliculogenesis (AB-01) Raijkovic A (US) 14:55 Follicle and oocyte aging (AB-02) Artini PG (IT) 15:20 Reproductive hormone receptor dynamics in developing follicles (AB-03) Mason H (UK) 15:45 Androgens, follicle development, and oocyte quality (AB-04) Andersen CY (DK) 16:10 AMH, antral follicle count, and other parameters to predict COS and ART outcome (AB-05) Broekmans FJ (NL) 16:35 The endometrium in ovarian stimulation (AB-06) Macklon NS (UK) 17:00 COFFEE BREAK AUDITORIUM 17:30 FERRING PHARMACEUTICALS SYMPOSIUM GONADOTROPINS, BACK TO THE FUTURE? Chairperson: Ubaldi F (IT) 17:30 hCG, Progesterone and LH levels during ovarian stimulation: the GOOD, the BAD an the UGLY Platteau P (BE) 17:55 Progesterone and hCG driven LH activity in GnRH antagonist cycles Bosch E (ES) 18:20 Use of AMH to decide between GnRH agonists or antagonists in controlled ovarian stimulation Fleming R (UK) 18:45 Discussion 19:00 WELCOME RECEPTION at Castel dell’Ovo www.ovulationinduction2010.org Friday • 01 October AUDITORIUM SESSION II ANOVULATION AND 6 MILD STIMULATION Sponsored by MERCK SERONO PHARMACEUTICALS Chairpersons: Nardo L (UK), De Leo V (IT) 08:30 Aromatase inhibitors (AB-07) Requena A (ES) 08:55 Metformin update (AB-08) Palomba S (IT) 09:20 Low-dose gonadotropins in anovulation (AB-09) Hugues JN (FR) 09:45 Controlled ovarian stimulation for intrauterine insemination (AB-10) Somigliana E (IT) 10:10 Minimal ovarian stimulation for ART (AB-11) Fauser B (NL) 10:45 COFFEE BREAK AUDITORIUM 11:15 IBSA PHARMACEUTICALS SYMPOSIUM MANAGING PCOS PATIENTS IN ASSISTED REPRODUCTION Chairpersons: Loutradis D (GR), Requena A (ES) 11:15 Choice of GnRH analog regimens for controlled ovarian stimulation in PCOS (SS-01) Orvieto R (IL) 11:40 Use of highly purified FSH in PCOS (SS-02) Grudzinskas G (UK) 12:05 Effects of in vivo and in vitro gonadotropin supplementation in PCOS patients undergoing oocyte in vitro-maturation (SS-03) Fadini R (IT) 12:30 Discussion 13:00 LUNCH www.ovulationinduction2010.org Friday • 01 October AUDITORIUM SESSION III GnRH ANALOGS 7 Chairpersons: Hugues JN (FR), Colao A (IT) 14:00 Improving efficacy of GnRH antagonists (AB-12) Lambalk C (NL) 14:25 Pituitary suppression regimens in poor responders (AB-13) Sunkara SK, Braude P (UK) 14:50 Oral contraceptive pre-treatment in GnRH antagonist cycles (AB-14) Griesinger G (DE) 15:15 Final follicle maturation trigger with GnRH agonists (AB-15) Humaidan P (DK) 15:40 Luteal phase support of GnRH antagonist cycles (AB-16) Nardo L (UK) Room ARAGONESE 14:00 FREE ORAL CATALANA 16:00 COMMUNICATIONS SESSION I 16:15 COFFEE BREAK AUDITORIUM 17:00 SCHERING-PLOUGH PHARMACEUTICALS SYMPOSIUM NEW PERSPECTIVES IN CONTROLLED OVARIAN STIMULATION Chairpersons: Nappi C (IT), Perino A (IT) 17:00 Optimisation of rFSH protocols: a patient focused approach (SS-04) Alviggi C (IT) 17:25 Evolution and future of antagonist protocols (SS-05) Palermo R (IT) 17:50 Corifollitropin a novel long acting rFSH: clinical features and clinician’s perspective (SS-06) Devroey P (BE) 18:15 Discussion www.ovulationinduction2010.org Saturday • 02 October AUDITORIUM SESSION IV FSH FORMULATIONS 8 AND REGIMENS Chairpersons: Pal L (US), Benagiano G (IT) 08:30 FSH structure-function relationships (AB-17) Wide L (SE) 08:55 Design and action of hyperglycosilated recombinant FSH molecules (AB-18) Lustbader JW (US) 09:20 Androgen priming before FSH ovarian stimulation (AB-19) Fleming R (UK) 09:45 Effects of high-dose FSH regimens (AB-20) Pal L (US) 10:10 Gonadotropin stimulation and follicular phase progesterone levels: mechanisms and outcome (AB-21) Bosch E (ES) 10:35 Tridimensional automated ultrasound for monitoring ovarian stimulation (AB-22) Raine-Fenning N (UK) 11:00 COFFEE BREAK AUDITORIUM 11:30 MERCK SERONO PHARMACEUTICALS SYMPOSIUM THE FUTURE OF CONTROLLED OVARIAN STIMULATION: FROM REPRODUCTIVE PHYSIOLOGY AND GENOMICS TO INDIVIDUALIZED THERAPY Chairpersons: Lenzi A (IT), Levi-Setti P (IT) 11:30 Welcome and introduction 11:40 Role and responsibilities of LH during early follicular growth: gonadal and extra gonadal effects (SS-07) Andersen CY (DK) 12:00 Customized COS to patients needs (SS-08) Humaidan P (DK) 12:20 From Subjectivity to Objectivity in gametes/embryo selection (SS-09) Montag M (DE) 12:40 LH vs hCG in endometrial gene expression profile (SS-10) Horcajadas JA (ES) 13:00 LUNCH www.ovulationinduction2010.org Saturday • 02 October AUDITORIUM SESSION V LH ACTIVITY: FORMULATIONS AND REGIMENS 9 Sponsored by FERRING PHARMACEUTICALS Chairpersons: Pellicer A (ES), Aboulghar M (EG) 14:00 LH activity-containing gonadotropin preparations (AB-23) Ubaldi F (IT) 14:25 Orally active LH agonists (AB-24) Van de Lagemaat R (NL) 14:50 Clinical use of recombinant LH (AB-25) Alviggi C (IT) 15:15 hCG in ovarian stimulation (AB-26) Filicori M (IT) 15:40 LH activity supplementation during GnRH antagonist cycles (AB-27) Devroey P (BE) Room ARAGONESE 14:00 FREE ORAL CATALANA
Load more

Recommended publications
  • ADVANCE ARTICLE: Endocrine Review S
    Two hormones for one receptor: evolution, biochemistry, actions and pathophysiology of LH and hCG Livio Casarini, Daniele Santi, Giulia Brigante, Manuela Simoni Endocrine Reviews Endocrine Society Submitted: February 23, 2018 Accepted: June 08, 2018 First Online: June 13, 2018 Advance Articles are PDF versions of manuscripts that have been peer reviewed and accepted but Endocrine Reviews not yet copyedited. The manuscripts are published online as soon as possible after acceptance and before the copyedited, typeset articles are published. They are posted "as is" (i.e., as submitted by the authors at the modification stage), and do not reflect editorial changes. No corrections/changes to the PDF manuscripts are accepted. Accordingly, there likely will be differences between the Advance Article manuscripts and the final, typeset articles. The manuscripts remain listed on the Advance Article page until the final, typeset articles are posted. At that point, the manuscripts are removed from the Advance Article page. DISCLAIMER: These manuscripts are provided "as is" without warranty of any kind, either express or particular purpose, or non-infringement. Changes will be made to these manuscripts before publication. Review and/or use or reliance on these materials is at the discretion and risk of the reader/user. In no event shall the Endocrine Society be liable for damages of any kind arising references to, products or publications do not imply endorsement of that product or publication. ADVANCE ARTICLE: Downloaded from https://academic.oup.com/edrv/advance-article-abstract/doi/10.1210/er.2018-00065/5036715 by Ombretta Malavasi user on 19 July 2018 Endocrine Reviews; Copyright 2018 DOI: 10.1210/er.2018-00065 Differences between LH and hCG Two hormones for one receptor: evolution, biochemistry, actions and pathophysiology of LH and hCG Livio Casarini1,2, Daniele Santi1,3, Giulia Brigante1,3, Manuela Simoni1,2,3 1.
    [Show full text]
  • Female Infertility and Assisted Reproduction: Impact of Oxidative Stress-- an Update
    Send Orders of Reprints at [email protected] Current Women’s Health Reviews, 2012, 8, 183-207 183 Female Infertility and Assisted Reproduction: Impact of Oxidative Stress-- An Update Beena J. Premkumar and Ashok Agarwal* Center for Reproductive Medicine, Cleveland Clinic, Cleveland, USA Abstract: Augmented levels of reactive oxygen species (ROS) that overpower the body’s antioxidant defenses result in oxidative stress (OS). Physiologically balanced levels of ROS and antioxidants maintain homeostasis in the body and allow for normal physiological processes to proceed. Physiological processes that involve oxygen consumption inevitably produce ROS. However, an overabundance of ROS leads to widespread injury to cells, and can damage DNA, lipid membranes, and proteins. An unfavorable reproductive environment hinders normal physiology secondary to this disruption of homeostasis. Infertility may be attributed to reproductive pathologies, leading to OS. Infertile couples often turn to assisted reproductive techniques (ART) to improve their chances for a successful pregnancy. In vitro techniques create an unfavorable environment for gametes and embryos by exposing them to a surplus of ROS in the absence of enzymatic antioxidant protection that normally exists in vivo. This article will review the currently available literature on the effects of ROS and OS on ART outcomes. The role of antioxidant supplementation of ART culture media continues to be a subject of interest to increase the likelihood for ART success. Keywords: Antioxidants, assisted reproduction, female infertility, oxidative stress. BACKGROUND INFORMATION the role of OS in female infertility and its impact on gametes and embryos in the ART setting. Close to 10% of reproductive aged couples fail to conceive through natural means.
    [Show full text]
  • Monoamine Oxidase a Is Highly Expressed by the Human Corpus Luteum of Pregnancy
    REPRODUCTIONRESEARCH Identification and characterization of an oocyte factor required for sperm decondensation in pig Jingyu Li*, Yanjun Huan1,*, Bingteng Xie, Jiaqiang Wang, Yanhua Zhao, Mingxia Jiao, Tianqing Huang, Qingran Kong and Zhonghua Liu Laboratory of Embryo Biotechnology, College of Life Science, Northeast Agricultural University, Harbin, Heilongjiang Province 150030, China and 1Shandong Academy of Agricultural Sciences, Dairy Cattle Research Center, Jinan, Shandong Province 250100, China Correspondence should be addressed to Z Liu; Email: [email protected] or to Q Kong; Email: [email protected] *(J Li and Y Huan contributed equally to this work) Abstract Mammalian oocytes possess factors to support fertilization and embryonic development, but knowledge on these oocyte-specific factors is limited. In the current study, we demonstrated that porcine oocytes with the first polar body collected at 33 h of in vitro maturation sustain IVF with higher sperm decondensation and pronuclear formation rates and support in vitro development with higher cleavage and blastocyst rates, compared with those collected at 42 h (P!0.05). Proteomic analysis performed to clarify the mechanisms underlying the differences in developmental competence between oocytes collected at 33 and 42 h led to the identification of 18 differentially expressed proteins, among which protein disulfide isomerase associated 3 (PDIA3) was selected for further study. Inhibition of maternal PDIA3 via antibody injection disrupted sperm decondensation; conversely, overexpression of PDIA3 in oocytes improved sperm decondensation. In addition, sperm decondensation failure in PDIA3 antibody-injected oocytes was rescued by dithiothreitol, a commonly used disulfide bond reducer. Our results collectively report that maternal PDIA3 plays a crucial role in sperm decondensation by reducing protamine disulfide bonds in porcine oocytes, supporting its utility as a potential tool for oocyte selection in assisted reproduction techniques.
    [Show full text]
  • Oocyte Selection for in Vitro Embryo Production in Livestock Species: Non-Invasive Approaches for the New Challenges of Oocyte Competence
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 22 October 2020 doi:10.20944/preprints202010.0453.v1 Review Oocyte selection for in vitro embryo production in livestock species: non-invasive approaches for the new challenges of oocyte competence Luis Aguila1*, Favian Treulen2, Jacinthe Therrien3, Ricardo Felmer4, Martha Valdivia5 and Smith Lawrence C6 1 Centre de Recherche en Reproduction et Fértilité (CRRF), Université de Montréal, St-Hyacinthe, QC, Canada; [email protected] 2 School of Medical Technology, Faculty of Science, Universidad Mayor, Temuco, Chile; [email protected] 3 Centre de Recherche en Reproduction et Fértilité (CRRF), Université de Montréal, St-Hyacinthe, QC, Canada; [email protected] 4 Laboratory of Reproduction, Centre of Reproductive Biotechnology (CEBIOR-BIOREN), Faculty of Medicine, Universidad de La Frontera, Temuco, Chile; [email protected]. 5 Laboratory of Animal Reproductive Physiology, Biological Sciences Faculty, Universidad Nacional Mayor de San Marcos, Lima, Peru; [email protected] 6 Centre de Recherche en Reproduction et Fértilité (CRRF), Université de Montréal, St-Hyacinthe, QC, Canada; [email protected] * Correspondence: [email protected] Simple Summary: The efficiency of producing embryos using in vitro technologies in livestock species remains lower when compared to mice, indicating that the proportion of female gametes that fail to develop after in vitro manipulation is considerably large. Considering that the intrinsic quality of the oocyte is one of the main factors affecting embryo production, the precise identification of non-invasive markers that predict oocyte competence is of major interest. The aim of this review was to explore the current literature on different non-invasive markers associated with oocyte quality in mammalian species, with an emphasis on the bovine model.
    [Show full text]
  • Research Paper the Role of MEMS in In-Vitro-Fertilization
    Adv. Technol. 2021, 1(1), 235-254 Research Paper The Role of MEMS in In-Vitro-Fertilization I. D. Wijegunawardanaa,* and Y. W. R. Amarasingheb,c a Department of Materials and Mechanical Technology, University of Sri Jayewardenepura, Pitipana, Homagama 10200, Sri Lanka b Department of Mechanical Engineering, University of Moratuwa, Katubadda 10400, Sri Lanka c Centre for Advanced Mechatronic Systems (CFAMS), University of Moratuwa, Katubadda 10400, Sri Lanka Email correspondence: [email protected] (I. D. Wijegunawardana) Received: 21 March 2021; Revised: 28 April 2021; Accepted: 23 May 2021; Published: 31 May 2021 Abstract The assisted reproduction has been considered a viable solution for the infertility of humankind for more than four decades. In-Vitro-Fertilization (IVF) is one of the most successful assisted reproduction techniques, where the reproductive cell of the female partner is fertilized outside of her body. Initially, the IVF process has been conducted manually by an experienced embryologist. However, even with a highly experienced individual, the operation had extremely lower success rates due to the limited control in environmental conditions and the requirement of precise movements. Therefore, to address this technological deficit, the feasibility of the mechatronics devices for IVF procedures has been investigated. Among the different mechatronics concepts, micro- electromechanical system (MEMS) technologies have been gradually attracted to the IVF process and improved its capabilities. The purpose of this paper is to present a brief overview of the role of MEMS technologies in IVF. The article classifies the MEMS technologies in IVF based on their application in order to emphasize its contribution. In addition, the article extensively discusses the state-of-the-art mechatronic techniques utilized in Intracytoplasmic Sperm Injection (ICSI), one of the most popular techniques used in IVF.
    [Show full text]
  • Cell Adhesion Molecules and in Vitro Fertilization
    in vivo 28: 683-690 (2014) Review Cell Adhesion Molecules and In Vitro Fertilization MARIA SIMOPOULOU1, ELENA NIKOLOPOULOU1, ANDREAS DIMAKAKOS1, KONSTANTINOS CHARALABOPOULOS2 and MICHAEL KOUTSILIERIS1 1Department of Physiology, University of Athens Medical School, Athens, Greece; 2Department of Physiology, Democritus University of Thrace Medical School, Alexandroupolis, Greece Abstract. This review addresses issues regarding the need in to enrich the list of non-invasive selection and predictive the in vitro fertilization (IVF) field for further predictive criteria in the IVF setting. We propose that in light of the well- markers enhancing the standing embryo selection criteria. It documented involvement of CAMs in the developmental aims to serve as a source of defining information for an processes of fertilization, embryogenesis, implantation, audience interested in factors related to the wide range of placentation, and embryonic development, further studies multiple roles played by cell adhesion molecules (CAMs) in could contribute significantly to achieving a higher quality of several aspects of IVF ultimately associated with the success treatment and management of infertility. of an IVF cycle. We begin by stressing the importance of enriching the standing embryo selection criteria available From enabling fatherhood for azoospermic men through the aiming for the golden standard: “extract as much information innovation of intra-cytoplasmic sperm injection and offering as possible focusing on non-invasive techniques” so as to solutions to infertile couples through gamete and embryo guide us towards selecting the embryo with the highest donation and surrogacy, to providing the basis enabling implantation potential. We briefly describe the latest trends on genetic embryo selection prior to implantation employing how to best select the right embryo, moving closer towards preimplantation genetic diagnosis (1), the world of in vitro elective single embryo transfer.
    [Show full text]
  • Outlook Emerging Technologies for the Molecular Study of Infertility, and Potential Clinical Applications
    RBMOnline - Vol 15 No 4. 2007 451-456 Reproductive BioMedicine Online; www.rbmonline.com/Article//2988 on web 17 August 2007 Outlook Emerging technologies for the molecular study of infertility, and potential clinical applications Dr Ashok Agarwal is a Professor in the Lerner College of Medicine at Case Western Reserve University and the Director of Reproductive Research Center, and the Clinical Andrology Laboratory at The Cleveland Clinic, Cleveland, Ohio, United States. He has published over 300 scientific articles, reviews and book chapters in different areas of andrology and reproductive biology. His long-term research interests include studies on the role of oxidative stress, DNA integrity, and apoptosis in the pathophysiology of male and female reproduction. Dr Ashok Agarwal Alex C Varghese1,2, Eric Goldberg3, Asok K Bhattacharyya1,2, Ashok Agarwal3,4 1DeCode Life Foundation; 2 Department of Biochemistry, University of Calcutta, Kolkata, India; 3Reproductive Research Centre, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA 4Correspondence: Tel: +1 216 4449485; Fax: +1 216 4456049; e-mail: [email protected] Abstract The techniques currently used to treat infertility cases are quite limited in their capabilities, due to an incomplete understanding of the molecular activities of germ cells. Fortunately, several technologies are presently being researched that should aid in the understanding of the various molecular causes of germ cell pathologies. This review discusses microarray technology, proteomics, metabolic profiling, the PolScope, atomic force microscopy and microfluidics. These technologies have all seen success in preliminary studies, and promise directly or indirectly to improve the low success rates of IVF and other related therapies.
    [Show full text]
  • Effects of Ovarian Stimulation on Oocyte Development and Embryo Quality
    EFFECTS OF OVARIAN STIMULATION ON OOCYTE DEVELOPMENT AND EMBRYO QUALITY By Kimberley Marie Swann BSc (Hons), MMedSci Thesis submitted to the University of Nottingham for the degree of Doctor of Philosophy May 2014 School of Clinical Sciences Queens Medical Centre Nottingham NG7 2UH DECLARATION I hereby declare that the work in this thesis has been devised, conducted and composed by myself and has not been submitted for any other degree, in Nottingham or elsewhere. The work presented herein is my own, where other sources have been used, the authors have been duly acknowledged. Kimberley Marie Swann Abstract ABSTRACT Ovarian stimulation plays a pivotal role in assisted reproductive therapies, to increase the number of embryos available for treatment; however, there is no clear consensus from meta-analyses in the literature which, if any, of the preparations in use are superior in terms of clinical outcomes. The aim of this thesis was to examine the effect of common human gonadotrophin preparations with different half lives and LH activity (hMG, rFSH and Pergoveris) on embryo quality and resulting offspring, compared to non- stimulated negative controls and positive PMSG treated controls, using the mouse model. The studies in this thesis indicated that an LH ceiling threshold is evident during folliculogenesis, where the use of long acting LH preparations resulted in higher numbers of fragmented oocytes, absent of cumulus cells (P<0.001), reduced expression of the pro and anti-angiogenic factors, MYHII and PEDF in cumulus cells (P<0.05), increased embryonic developmental arrest (P<0.001) and perturbed IGF2 (P<0.05) and VEGFA gene expression in resulting blastocysts (P<0.01), compared to negative controls.
    [Show full text]
  • ASRM 75Th Scientific Congress – POSTERS Tuesday, October 15
    Click on the th PosterPlus ASRM 75 Scientific Congress – POSTERS button in the ASRM meeting Tuesday, October 15, 2019 • 6:30 AM – 7:45 AM app to see bonus content for participating PCC Expo Hall, Poster Area poster presenters. ACCESS TO CARE P-71 EMBRYO EUPLOIDY RATES DIFFER IN SAME-SEX MALE COUPLES UTILIZING A SINGLE OVUM P-136 RELATIONSHIP BETWEEN THE PREGNANCY AND THE SIZE OF ARRESTED BLASTOMERE P-1 DOES AN INSURANCE MANDATE TO COVER INFERTILITY TREATMENT INCREASE ACCESS TO IN DONOR. N. E. Ramos DERIVED FROM ABNORMAL CYTOKINESIS IN BLASTOCYST TRANSFER CYCLES. H. Izumi VITRO FERTILIZATION? K. Payne P-72 ANEUPLOIDY RATE IN BRCA CARRIERS IS SIMILAR TO AGE-MATCHED INFERTILE WOMEN. M. P-137 EMBRYO SELECT ASSAY: A NON-INVASIVE, DIPSTICK ELISA STRIP ASSAY TO IDENTIFY THE MOST P-2 DEFINING INFERTILITY: HOW THE LANGUAGE USED TO DESCRIBE INFERTILITY SHAPES PUBLIC Facadio Antero COMPETENT EMBRYO FROM THE COHORT. E. E. Puscheck PERCEPTION AND POLICY. A. C. Mancuso P-73 SUBOPTIMAL STIMULATION IS PREDICTIVE OF INCREASED ANEUPLOIDY AND REDUCED P-138 SINGLE VITRIFIED-WARMED BLASTOCYST TRANSFER: WHAT ARE THE BEST PREDICTIVE P-3 PATIENT ACCESS AND UNTAPPED POTENTIAL: CAN NEW DATA DRIVE PROGRESS? H. Taske PREGNANCIES PER CYCLE START. J. B. Whitney FACTORS FOR SUCCESS? E. Boulet P-4 GENDER AND FERTILITY STATUS AFFECT PERCEPTIONS OF INFERTILITY AND SUPPORT FOR FERTILITY PRESERVATION P-139 MATURITY OF CUMULUS OOCYTE COMPLEX (COC) PREDICTS THE OUTCOME OF ART. ~ FOCUS ACCESS TO CARE: A CROSS SECTIONAL STUDY. R. K. Chung P-74 ESTIMATES OF INFERTILITY IN AN ERA OF INCREASING STI RATES, 2002-2015.
    [Show full text]
  • Original Investigation Ovarian Stimulation Drugs Alter The
    1 Original Investigation Ovarian stimulation drugs alter the metabolite content of the growing follicle: in-vivo spectroscopic evaluation of follicle fluid Güngör and Güngör. Ovarian stimulation drugs alter the follicle Nur Dokuzeylül Güngör1, Kağan Güngör2 1Clinic of Reproductive Endocrinology and IVF, BAU Medical Park Göztepe Hospital, İstanbul, Turkey 2Clinic of Endocrinology and Metabolism, İstanbul Medeniyet University, Göztepe Training and Research Hospital, İstanbul, Turkey Adress for Correspondence: Nur Dokuzeylül Güngör Phone: +90 532 383 49 65 e-mail: [email protected] ORCID ID: orcid.org/0000- 0002-7234-3876 DOI: 10.4274/jtgga.galenos.2020.2020.0104 Received: 29 June, 2020 Accepted: 09 December, 2020 Proof Abstract Objective: By using magnetic resonance spectroscopy (MRS) to determine metabolite content of growing nfollicle in patients with polycystic ovary syndrome (PCOS) receiving recombinant FSH, clomiphene citrate (CC) or aromatase inhibitor (AI) for ovarian stimulation. Material and Methods: 30 patients diagnosed with PCOS and infertility and scheduled for ovarian stimulation were divided into 3 equal groups according to the drugs they took as follows: rFSH (n: 10), or CC (n: 10), or AI (n = 10). Five fertile cases were determined as the control group. When the follicle diameters reached 16-18 mm in each group, patients were directed to the MRS and the metabolite content of a dominant follicle was analyzed. N- acetylaspartate (NAA), lactate (Lac), creatine (Cr), and choline (Cho) metabolite levels determined in the spectrum were measured in ppm. Results: Approximately 3-fold decrease in dominant follicle Cho content was found in patients receiving CC compared to control subjects. Similarly, the dominant follicle Cho intensities of patients given rFSH and AI were noted to be significantly higher than those who received CC.
    [Show full text]
  • International Journal of Modern Pharmaceutical Research
    IJMPR 2021, 5(2), 105-110 ISSN: 2319-5878 IJMPR Sangeetha. International Journal of Modern Pharmaceutical Research 105 International Journal of Modern Review Article Pharmaceutical Research SJIF Impact Factor: 5.273 www.ijmpronline.com INVITRO FERTILIZATION – ITS ROLE, IMPORTANCE AND RISK FACTORS S. Sangeetha* Lecturer, Department of Anatomy, Saveetha Dental College, Saveetha Institute of Medical sciences And Technology (SIMATS) Saveetha University, Chennai-600077. Received on: 25/02/2021 ABSTRACT Revised on: 15/03/2021 In vitro fertilisation (IVF) is a process of fertilisation where an egg is combined Accepted on: 05/04/2021 with sperm outside the body, in vitro ("in glass"). The process involves monitoring and stimulating a woman's ovulatory process, removing an ovum or ova (egg or eggs) from *Corresponding Author the woman's ovaries and letting sperm fertilise them in a liquid in a laboratory. After S. Sangeetha the fertilised egg (zygote) undergoes embryo culture for 2–6 days, it is implanted in the same or another woman's uterus, with the intention of establishing a successful Lecturer, Department of pregnancy. IVF is a type of assisted reproductive technology used for infertility Anatomy, Saveetha Dental treatment and gestational surrogacy. A fertilised egg may be implanted into a College, Saveetha Institute of surrogate's uterus, and the resulting child is genetically unrelated to the surrogate. Medical sciences And Some countries have banned or otherwise regulate the availability of IVF treatment, Technology (SIMATS) giving rise to fertility tourism. Restrictions on the availability of IVF include costs and age, in order for a woman to carry a healthy pregnancy to term.
    [Show full text]
  • Oocyte Selection for in Vitro Embryo Production in Bovine Species: Noninvasive Approaches for New Challenges of Oocyte Competence
    animals Review Oocyte Selection for In Vitro Embryo Production in Bovine Species: Noninvasive Approaches for New Challenges of Oocyte Competence Luis Aguila 1,* , Favian Treulen 2, Jacinthe Therrien 1, Ricardo Felmer 3, Martha Valdivia 4 and Lawrence C Smith 1 1 Centre de Recherche en Reproduction et Fértilité (CRRF), Université de Montréal, St-Hyacinthe, QC J2S 2M2, Canada; [email protected] (J.T.); [email protected] (L.C.S.) 2 School of Medical Technology, Faculty of Science, Universidad Mayor, Temuco 4801043, Chile; [email protected] 3 Laboratory of Reproduction, Centre of Reproductive Biotechnology (CEBIOR-BIOREN), Faculty of Medicine, Universidad de La Frontera, Temuco 4811322, Chile; [email protected] 4 Laboratory of Animal Reproductive Physiology, Biological Sciences Faculty, Universidad Nacional Mayor de San Marcos, Lima 15088, Peru; [email protected] * Correspondence: [email protected] Received: 20 October 2020; Accepted: 19 November 2020; Published: 24 November 2020 Simple Summary: The efficiency of producing embryos using in vitro technologies in cattle species remains lower when compared to mice, indicating that the proportion of female gametes that fail to develop after in vitro manipulation is considerably large. Considering that the intrinsic quality of the oocyte is one of the main factors affecting embryo production, the precise identification of noninvasive markers that predict oocyte competence is of major interest. The aim of this review was to explore the current literature on different noninvasive markers associated with oocyte quality in the bovine model. Apart from some controversial findings, the presence of cycle-related structures in ovaries, a follicle size between 6 and 10 mm, a large slightly expanded investment without dark areas, large oocyte diameter (>120 microns), dark cytoplasm, and the presence of a round and smooth first polar body have been associated with better embryonic development.
    [Show full text]